赵瑾, 李俊, 许慧琳, 李为希, 李晔, 胡敏. 低剂量CT筛查肺癌的经济学评价研究进展及思考[J]. 上海预防医学, 2021, 33(4): 280-286. DOI: 10.19428/j.cnki.sjpm.2021.20445
引用本文: 赵瑾, 李俊, 许慧琳, 李为希, 李晔, 胡敏. 低剂量CT筛查肺癌的经济学评价研究进展及思考[J]. 上海预防医学, 2021, 33(4): 280-286. DOI: 10.19428/j.cnki.sjpm.2021.20445
ZHAO Jin, LI Jun, XU Hui-lin, LI Wei-xi, LI Ye, HU Min. Review of economic evaluation of lung cancer screening with low-dose computed tomography[J]. Shanghai Journal of Preventive Medicine, 2021, 33(4): 280-286. DOI: 10.19428/j.cnki.sjpm.2021.20445
Citation: ZHAO Jin, LI Jun, XU Hui-lin, LI Wei-xi, LI Ye, HU Min. Review of economic evaluation of lung cancer screening with low-dose computed tomography[J]. Shanghai Journal of Preventive Medicine, 2021, 33(4): 280-286. DOI: 10.19428/j.cnki.sjpm.2021.20445

低剂量CT筛查肺癌的经济学评价研究进展及思考

Review of economic evaluation of lung cancer screening with low-dose computed tomography

  • 摘要:
    目的对近期国内外低剂量CT筛查肺癌的经济学评价研究进行分析与归纳,为中国肺癌筛查的经济学评价研究提供建议和参考。
    方法系统检索并分析2015-2019年国内外发表的低剂量CT筛查肺癌的经济学评价文献。
    结果根据文献纳入标准选入15篇肺癌低剂量CT筛查的文献,均为英文文献,研究多在欧美发达国家开展,绝大部分采用模型模拟结果,其中13项研究表明低剂量CT筛查肺癌与无筛查或X线胸片筛查肺癌相比具有成本效果,2项研究的结果显示不具有成本效果。
    结论现有的经济学评价证据表明,低剂量CT筛查肺癌具有成本效果,越来越多的研究使用微观模拟模型从个体层面进行评估。但低剂量CT筛查肺癌具有成本效果在发展中国家的证据尚不充分,有必要结合我国的肺癌筛查实践和本土化数据开展经济学评价研究。

     

    Abstract:
    ObjectiveTo analyze recent economic evaluation studies of low-dose CT screening for lung cancer in order to provide recommendations for such economic evaluation in China.
    MethodsA systematic search and analysis was conducted to identify articles on low-dose CT screening for lung cancer published from 2015 to 2019.
    ResultsAccording to the literature inclusion criteria, 15 studies were included. Most of the studies were conducted in Europe, the United States and other developed countries. The majority adopted model simulation approaches. Low-dose CT screening was suggested to be cost-effective compared with no-screening or chest radiography for lung cancer in 13 studies. Only 2 studies showed no cost-effectiveness.
    ConclusionThe latest evidence of economic evaluation shows that low-dose CT screening for lung cancer is cost-effective and has a more consistent result than previous reviews. Methodologically, use of microsimulation models is increasing for better economic evaluation at the individual level. However, evidence from developing countries is still insufficient. It is necessary to conduct economic evaluation in combination with the domestic practice of lung cancer screening and localized data.

     

/

返回文章
返回